Poland· PL-100187018
Ladybon
A g03dc05 product containing tibolonum, registered in Poland by Zentiva, k.s..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Tibolonum
- Manufacturer
- Zentiva, k.s.
- Country
- Poland (PL)
- ATC code
- G03DC05
- ATC class
- G03DC05
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990668854
- gtin05909990668861
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
G03dc05 in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomLivial 2.5mg tabletsWaymade Healthcare Plc
- SwitzerlandLivial, TablettenOrganon GmbH
- CzechiaLADYBONZentiva, k.s., Praha
- FranceLIVIAL 2,5 mg, compriméBB FARMA (ITALIE)
- SpainBOLTIN 2,5 mg COMPRIMIDOSOrganon Salud S.L.
- FinlandLivialN.V. Organon
- ItalyLIVIALORGANON ITALIA S.R.L.
- SwedenLivial 2,5 mg TablettNV Organon
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Liviel, Tiloria
- Belgium · Heria, Livial
- Bulgaria · Айвиал, Ливиал
- Cyprus · Livial
- Czechia · Ladybon, Livial
- Germany · Liviella, Tibolon Aristo
- Denmark · Livial, Tibocina
- Spain · Boltin, Tibicare
- Finland · Livial, Tibocina
- France · Livial, Tibolone Ccd
- United Kingdom (Northern Ireland) · Livial, Tibolone Aristo Pharma Gmbh
- Greece · Juliette, Livial
- Hungary · Ladybon, Livial
- Ireland · Livial, Tibolone Aristo
- Iceland · Livial
- Italy · Livial, Menec
- Lithuania · Livial
- Luxembourg · Heria, Livial
- Netherlands · Livial, Tibolinia
- Norway · Livial, Tibocina
- Portugal · Clitax, Goldar
- Romania · Livial
- Sweden · Livial, Tibelia
- Slovenia · Livial
- Slovakia · Ladybon, Livial
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/abe61f77-b4fc-4f17-ab10-7bf7408f0416 GET /v1/drugs/abe61f77-b4fc-4f17-ab10-7bf7408f0416?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "2,5 mg",
"packaging": "05909990668854 ¦ Rp ¦ 46468\n28 tabl.\n05909990668861 ¦ Rp ¦ 46469\n84 tabl.",
"substance": "Tibolonum 2.5 mg",
"common_name": "Tibolonum",
"pl_product_id": "100187018",
"pozwolenie_nr": "14953",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about g03dc05.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.